Have your own idea? Try our Stock Screener
Swiss (SMI) Drug Retail Industry Analysis
UpdatedAug 31, 2025
DataAggregated Company Financials
Companies1
- 7D-5.3%
- 3M-24.8%
- 1Y-82.9%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 11%, driven by gains from every company within the industry. However, the industry is down 83% over the past year. Looking forward, earnings are forecast to grow by 44% annually.
Industry Valuation and Performance
Has the Swiss Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 31 Aug 2025 | CHF 316.8m | CHF 1.1b | -CHF 120,874,000.00 | n/a | -2.6x | 0.3x |
| Tue, 29 Jul 2025 | CHF 391.9m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -3.4x | 0.4x |
| Thu, 26 Jun 2025 | CHF 305.0m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -2.7x | 0.3x |
| Sat, 24 May 2025 | CHF 446.4m | CHF 1.1b | -CHF 113,612,000.00 | n/a | -3.9x | 0.4x |
| Mon, 21 Apr 2025 | CHF 241.1m | CHF 1.0b | -CHF 97,253,000.00 | n/a | -2.5x | 0.2x |
| Wed, 19 Mar 2025 | CHF 216.5m | CHF 1.0b | -CHF 97,253,000.00 | n/a | -2.2x | 0.2x |
| Fri, 14 Feb 2025 | CHF 235.9m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -2.4x | 0.2x |
| Sun, 12 Jan 2025 | CHF 252.9m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -2.6x | 0.3x |
| Tue, 10 Dec 2024 | CHF 334.8m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -3.4x | 0.3x |
| Thu, 07 Nov 2024 | CHF 430.8m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.4x | 0.4x |
| Sat, 05 Oct 2024 | CHF 405.2m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -4.2x | 0.4x |
| Mon, 02 Sep 2024 | CHF 498.6m | CHF 1.0b | -CHF 97,259,000.00 | n/a | -5.1x | 0.5x |
| Wed, 31 Jul 2024 | CHF 583.3m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -5x | 0.6x |
| Fri, 28 Jun 2024 | CHF 690.5m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -5.9x | 0.7x |
| Sun, 26 May 2024 | CHF 805.1m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -6.8x | 0.8x |
| Tue, 23 Apr 2024 | CHF 962.2m | CHF 969.5m | -CHF 117,565,000.00 | n/a | -8.2x | 1x |
| Thu, 21 Mar 2024 | CHF 938.4m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -6.4x | 0.6x |
| Sat, 17 Feb 2024 | CHF 1.1b | CHF 1.6b | -CHF 145,782,000.00 | n/a | -7.4x | 0.7x |
| Mon, 15 Jan 2024 | CHF 887.3m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -6.1x | 0.6x |
| Wed, 13 Dec 2023 | CHF 794.4m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -5.4x | 0.5x |
| Fri, 10 Nov 2023 | CHF 521.7m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -3.6x | 0.3x |
| Sun, 08 Oct 2023 | CHF 593.9m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -4.1x | 0.4x |
| Tue, 05 Sep 2023 | CHF 686.2m | CHF 1.6b | -CHF 145,782,000.00 | n/a | -4.7x | 0.4x |
| Thu, 03 Aug 2023 | CHF 574.4m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -3.4x | 0.4x |
| Sat, 01 Jul 2023 | CHF 456.7m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.7x | 0.3x |
| Mon, 29 May 2023 | CHF 357.3m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.1x | 0.2x |
| Wed, 26 Apr 2023 | CHF 437.8m | CHF 1.6b | -CHF 171,115,000.00 | n/a | -2.6x | 0.3x |
| Fri, 24 Mar 2023 | CHF 485.2m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.1x | 0.3x |
| Sun, 19 Feb 2023 | CHF 619.9m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.6x | 0.4x |
| Tue, 17 Jan 2023 | CHF 439.8m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.9x | 0.3x |
| Thu, 15 Dec 2022 | CHF 348.2m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.5x | 0.2x |
| Sat, 12 Nov 2022 | CHF 423.5m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.8x | 0.2x |
| Mon, 10 Oct 2022 | CHF 340.0m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -1.4x | 0.2x |
| Wed, 07 Sep 2022 | CHF 536.7m | CHF 1.7b | -CHF 234,788,000.00 | n/a | -2.3x | 0.3x |
Price to Earnings Ratio
-2.3x
Current Industry PE
- There is only one company in the Swiss Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 15% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Swiss Drug Retail compare with similar industries?
| CH Market | -0.82% | |
| Consumer Staples | 0.17% | |
| Food and Staples Retail | -3.95% | |
| Drug Retail | -5.31% | |
| Food Retail | 3.33% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||